Literature DB >> 7887439

Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.

S R Zaki1, P W Greer, L M Coffield, C S Goldsmith, K B Nolte, K Foucar, R M Feddersen, R E Zumwalt, G L Miller, A S Khan.   

Abstract

A recent outbreak of a severe pulmonary disease in the southwestern United States was etiologically linked to a previously unrecognized hantavirus. The virus has been isolated from its major reservoir, the deer mouse, Peromyscus maniculatus, and recently named Sin Nombre virus. Clinically, the disease has become known as the hantavirus pulmonary syndrome (HPS). Since May 1993, 44 fatal cases of HPS have been identified through clinicopathological review and immunohistochemical (IHC) testing of tissues from 273 patients who died of an unexplained noncardiogenic pulmonary edema. In 158 cases for which suitable specimens were available, serological testing and/or reverse transcription-polymerase chain reaction (RT-PCR) amplification of extracted RNA was also performed. IHC, serological, and PCR results were concordant for virtually all HPS and non-HPS patients when more than one assay was performed. The prodromal illness of HPS is similar to that of many other viral diseases. Consistent hematological features include thrombocytopenia, hemoconcentration, neutrophilic leukocytosis with a left shift, and reactive lymphocytes. Pulmonary histopathological features were similar in most of the fatal HPS cases (40/44) and consisted of an interstitial pneumonitis with a variable mononuclear cell infiltrate, edema, and focal hyaline membranes. In four cases, however, pulmonary features were significantly different and included diffuse alveolar damage and variable degrees of severe air space disorganization. IHC analysis showed widespread presence of hantaviral antigens in endothelial cells of the microvasculature, particularly in the lung. Hantaviral antigens were also observed within follicular dendritic cells, macrophages, and lymphocytes. Hantaviral inclusions were observed in endothelial cells of lungs by thinsection electron microscopy, and their identity was verified by immunogold labeling. Virus-like particles were seen in pulmonary endothelial cells and macrophages. HPS is a newly recognized, often fatal disease, with a spectrum of microscopic morphological changes, which may be an important cause of severe and fatal illness presenting as adult respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887439      PMCID: PMC1869168     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  67 in total

1.  CLINICAL ANALYSIS OF 111 FATAL CASES OF EPIDEMIC HEMORRHAGIC FEVER.

Authors:  D KIM
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

2.  Hemorrhagic fever: a study of 300 cases.

Authors:  G M POWELL
Journal:  Medicine (Baltimore)       Date:  1954-05       Impact factor: 1.889

3.  Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses.

Authors:  R Yanagihara; D J Silverman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 4.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Genome structure and variability of a virus causing hantavirus pulmonary syndrome.

Authors:  C F Spiropoulou; S Morzunov; H Feldmann; A Sanchez; C J Peters; S T Nichol
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

6.  Hantavirus pulmonary syndrome: an emerging infectious disease.

Authors:  J M Hughes; C J Peters; M L Cohen; B W Mahy
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

Review 7.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome.

Authors:  H Feldmann; A Sanchez; S Morzunov; C F Spiropoulou; P E Rollin; T G Ksiazek; C J Peters; S T Nichol
Journal:  Virus Res       Date:  1993-12       Impact factor: 3.303

9.  Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever H.

Authors:  S Kim; E T Kang; Y G Kim; J S Han; J S Lee; Y I Kim; W C Hall; J M Dalrymple; C J Peters
Journal:  Am J Clin Pathol       Date:  1993-10       Impact factor: 2.493

10.  A retrospective analysis of sera collected by the Hemorrhagic Fever Commission during the Korean Conflict.

Authors:  J W LeDuc; T G Ksiazek; C A Rossi; J M Dalrymple
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

View more
  214 in total

1.  Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.

Authors:  I N Gavrilovskaya; E J Brown; M H Ginsberg; E R Mackow
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.

Authors:  Kum Thong Wong; Wun-Ju Shieh; Shalini Kumar; Karim Norain; Wahidah Abdullah; Jeannette Guarner; Cynthia S Goldsmith; Kaw Bing Chua; Sai Kit Lam; Chong Tin Tan; Khean Jin Goh; Heng Thay Chong; Rani Jusoh; Pierre E Rollin; Thomas G Ksiazek; Sherif R Zaki
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro.

Authors:  S F Khaiboullina; D M Netski; P Krumpe; S C St Jeor
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice.

Authors:  Dominic Wichmann; Hermann-Josef Gröne; Michael Frese; Jovan Pavlovic; Bärbel Anheier; Otto Haller; Hans-Dieter Klenk; Heinz Feldmann
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 5.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

6.  Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus.

Authors:  Tony Schountz; Mariana Acuña-Retamar; Shira Feinstein; Joseph Prescott; Fernando Torres-Perez; Brendan Podell; Staci Peters; Chunyan Ye; William C Black; Brian Hjelle
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

7.  Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques.

Authors:  David Safronetz; Joseph Prescott; Friederike Feldmann; Elaine Haddock; Rebecca Rosenke; Atsushi Okumura; Douglas Brining; Eric Dahlstrom; Stephen F Porcella; Hideki Ebihara; Dana P Scott; Brian Hjelle; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail.

Authors:  Erika Geimonen; Imelyn Fernandez; Irina N Gavrilovskaya; Erich R Mackow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus.

Authors:  Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

10.  Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.

Authors:  Victoria Wahl-Jensen; Jennifer Chapman; Ludmila Asher; Robert Fisher; Michael Zimmerman; Tom Larsen; Jay W Hooper
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.